Journal of Telemedicine and Telecare > Volume 15, Number 3 > Pp. 125-128

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Istepanian, R. S. Articles by Earle, K. A Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

PAPERS

Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes

Robert SH Istepanian ^*, Karima Zitouni ^*, Diane Harry , Niva Moutosammy , Ala Sungoor ^*, Bee Tang ^* and Kenneth A Earle  

^* Mobile Information and Network Technologies Centre, Kingston University, London; St George's Hospital NHS Trust, London, UK

Correspondence: Dr K A Earle, Department of Cellular and Molecular Medicine, St George's Hospital NHS Trust, London SW17 ORE, UK (Fax: +44 20 8725 1353; Email: k.earle{at}sgul.ac.uk)

We conducted a randomized controlled trial using mobile health technology in an ethnically diverse sample of 137 patients with complicated diabetes. Patients in the intervention group (n = 72) were trained to measure their blood glucose with a sensor which transmitted the readings to a mobile phone via a Bluetooth wireless link. Clinicians were then able to examine and respond to the readings which were viewed with a web-based application. Patients in the control arm of the study (n = 65) did not transmit their readings and received care with their usual doctor in the outpatient and/or primary care setting. The mean follow-up period was 9 months in each group. The default rate was higher in the patients in the intervention arm due to technical problems. In an intention-to-treat analysis there were no differences in HbA_1c between the intervention and control groups. In a sub-group analysis of the patients who completed the study, the telemonitoring group had a lower HbA_1c than those in the control group: 7.76% and 8.40%, respectively (P = 0.06).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?